ONTOGEN MEDTECH

Lisle, IL · Medtech · Private

Catheter-directed thrombolysis catheter with real-time pressure monitoring for personalized pulmonary embolism treatment

ontogenmedtech.com →
Grants
$518K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Novel Catheter for Thrombolytic Drug Infusion Therapy to treat Pulmonary Embolism$258,793
Federal grantDepartment of Health and Human Services · Phase I · A Novel Catheter for Thrombolytic Drug Infusion Therapy to treat Pulmonary Embolism$258,793
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1695ZBEATS, INC.——
1696MOLECULAR SURFACE TECHNOLOGIES LLC——
1697TEARDX, LLC——
1698ONTOGEN MEDTECH——
1699Amnio Technology, LLC—$50K
1700PASCALL Systems, Incorporated——
1701Peltier Technology Inc.—$5.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.